000 | 01782 a2200505 4500 | ||
---|---|---|---|
005 | 20250515210157.0 | ||
264 | 0 | _c20100712 | |
008 | 201007s 0 0 eng d | ||
022 | _a1098-1136 | ||
024 | 7 |
_a10.1002/glia.20977 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorisaki, Shinsuke | |
245 | 0 | 0 |
_aEndogenous glucocorticoids improve myelination via Schwann cells after peripheral nerve injury: An in vivo study using a crush injury model. _h[electronic resource] |
260 |
_bGlia _cJun 2010 |
||
300 |
_a954-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdrenalectomy |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCorticosterone _xadministration & dosage |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aIndoles |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyelin Basic Protein _xgenetics |
650 | 0 | 4 |
_aMyelin P0 Protein _xgenetics |
650 | 0 | 4 |
_aNerve Crush _xmethods |
650 | 0 | 4 |
_aNerve Regeneration _xdrug effects |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Glucocorticoid _xgenetics |
650 | 0 | 4 |
_aS100 Proteins _xmetabolism |
650 | 0 | 4 |
_aSchwann Cells _xdrug effects |
650 | 0 | 4 |
_aSciatic Neuropathy _xdrug therapy |
700 | 1 | _aNishi, Mayumi | |
700 | 1 | _aFujiwara, Hiroyoshi | |
700 | 1 | _aOda, Ryo | |
700 | 1 | _aKawata, Mitsuhiro | |
700 | 1 | _aKubo, Toshikazu | |
773 | 0 |
_tGlia _gvol. 58 _gno. 8 _gp. 954-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/glia.20977 _zAvailable from publisher's website |
999 |
_c19538995 _d19538995 |